CogniMed Oy, a leading speech and occupational therapy provider in Finland, has been acquired by Mehiläinen to enhance its therapy services across the country.
Target Company Overview
CogniMed Oy is a leading provider of speech and occupational therapy services in Finland, established in 2014. The company specializes in delivering high-quality therapy solutions for children, youth, and adults, primarily in the Helsinki metropolitan area, Pirkanmaa, and Turku. With a dedicated team of 80 professionals, CogniMed generated a revenue of approximately €6.6 million in 2023, underlining its significant presence in the healthcare market.
As a firm committed to fostering a healthy workforce and nurturing a supportive corporate culture, CogniMed prides itself on creating a positive environment that enables employees to deliver exceptional service to clients. This approach has been pivotal in shaping the company's operations, ensuring that high-quality therapy services remain at the forefront of its mission.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
The Finnish healthcare sector is characterized by a robust demand for specialized therapy services, including speech and occupational therapy. A growing emphasis on mental health and overall well-being, couple
Similar Deals
Mehiläinen → Toimivax Oy and Neurokuntoutus NH Oy
2025
Novartis AG → Avidity Biosciences, Inc.
2026
Mehiläinen
invested in
CogniMed Oy
in 2023
in a Merger deal
Disclosed details
Revenue: $7M